James A. Talcott

9.2k citations

94 papers · 6.7k indexed · 2 hit papers · h-index 38

Impact in

Clinical Biochemistry top 0.2%
- Bacterial Identification and Susceptibility Testing
Oncology top 0.5%
- Neutropenia and Cancer Infections
- Cancer survivorship and care

Papers in

Pulmonary and Respiratory Medicine 51
- Prostate Cancer Diagnosis and Treatment 42
- Prostate Cancer Treatment and Research 30
Oncology 36
- Neutropenia and Cancer Infections 16
- Cancer survivorship and care 9
- Global Cancer Incidence and Screening 9

Co-authors: Jack A. Clark Philip W. Kantoff Patricia P. Rieker Robert W. Finberg Robert D. Siegel L Goldman Ronald C. Chen Rebecca A. Silliman
Journals: Journal of Clinical Oncology (25 papers)Cancer (6 papers)International Journal of Radiation Oncology*Biology*Physics (6 papers)The Journal of Urology (5 papers)Urologic Oncology Seminars and Original Investigations (4 papers)
Partner nations: United States Canada Netherlands

In The Last Decade

James A. Talcott

92 papers receiving 6.4k citations

Hit Papers

align trajectories log scale

The Multinational Association for Supportive Care in Cancer Risk Index: A Multinational Scoring System for Identifying Low-Risk Febrile Neutropenic Cancer Patients 2000 · 768 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2000 Journal of Clinical Oncology
1997 Proceedings of the National Academy of Sciences

Peers

Countries citing papers authored by James A. Talcott

Since Specialization

Citations

This map shows the geographic impact of James A. Talcott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James A. Talcott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James A. Talcott more than expected).

Fields of papers citing papers by James A. Talcott

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James A. Talcott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James A. Talcott. The network helps show where James A. Talcott may publish in the future.

Co-authors

The 25 scholars most cited alongside James A. Talcott, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with James A. Talcott Line = papers co-authored together James A. Talcott links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Patient‐reported outcomes after 3‐dimensional conformal, intensity‐modulated, or proton beam radiotherapy for localized prostate cancer Cancer ·Phillip J. Gray, Jonathan J. Paly, Beow Y. Yeap, Martin G. Sanda, Howard M. Sandler, Jeff M. Michalski, James A. Talcott, John J. Coen, Daniel A. Hamstra, William U. Shipley, Stephen M. Hahn, Anthony L. Zietman, Justin E. Bekelman, Jason A. Efstathiou	2013	72
2	Bowel and bladder toxicity patterns in patients with prostate cancer treated with proton beam versus intensity-modulated radiation therapy. Journal of Clinical Oncology ·Phillip J. Gray, Jonathan J. Paly, Martin G. Sanda, Howard M. Sandler, Jeff M. Michalski, James A. Talcott, John J. Coen, William U. Shipley, Anthony L. Zietman, Justin E. Bekelman, Jason A. Efstathiou	2012	1
3	Long-Term Quality of Life Outcome After Proton Beam Monotherapy for Localized Prostate Cancer International Journal of Radiation OncologyBiologyPhysics ·John J. Coen, Jonathan J. Paly, Andrzej Niemierko, Elizabeth A. Weyman, Anita Rodrigues, William U. Shipley, Anthony L. Zietman, James A. Talcott	2011	26
4	Patient-Reported Long-term Outcomes After Conventional and High-Dose Combined Proton and Photon Radiation for Early Prostate Cancer JAMA ·James A. Talcott	2010	71
5	Race, healthcare access and physician trust among prostate cancer patients Cancer Causes & Control ·Young Kyung, William R. Carpenter, Pamela Spain, Jack A. Clark, Robert J. Hamilton, Joseph A. Galanko, Anne Jackman, James A. Talcott, Paul A. Godley	2009	50
6	Perceived family history risk and symptomatic diagnosis of prostate cancer Cancer ·Pamela Spain, William R. Carpenter, James A. Talcott, Jack A. Clark, Young Kyung, Robert J. Hamilton, Joseph A. Galanko, Anne Jackman, Paul A. Godley	2008	20
7	Androgen deprivation-mediated cytoreduction before interstitial brachytherapy for prostate cancer does not abrogate the elevated risk of urinary morbidity associated with larger initial prostate volume Brachytherapy ·Joshua H. Petit, Clifford Gluck, W. S. Kiger, Duncan Henry, Carol Karasiewicz, James A. Talcott, Solomon Berg, Edward J. Holupka, Irving Kaplan	2007	15
8	Hidden barriers between knowledge and behavior Cancer ·James A. Talcott, Pamela Spain, Jack A. Clark, William R. Carpenter, Young Kyung, Robert J. Hamilton, Joseph A. Galanko, Anne Jackman, Paul A. Godley	2007	66
9	Quality of life in prostate cancer European Journal of Cancer ·James A. Talcott, Jack A. Clark	2005	24
10	Patient-reported acute gastrointestinal toxicity in men receiving 3-dimensional conformal radiation therapy for prostate cancer with or without neoadjuvant androgen suppression therapy Urologic Oncology Seminars and Original Investigations ·Henry Tsai, Judith Manola, Anthony Abner, James A. Talcott, Anthony V. D’Amico, Clair J. Beard	2005	10
11	Organ Conservation in Invasive Bladder Cancer by Transurethral Resection, Chemotherapy and Radiation: Results of a Urodynamic and Quality of Life Study on Long-term Survivors The Journal of Urology ·Anthony L. Zietman, Dianne Sacco, URI SKOWRONSKI, Pablo Gomery, Donald S. Kaufman, Jack A. Clark, James A. Talcott, William U. Shipley	2003	180
12	United States radiation oncologists’ and urologists’ opinions about screening and treatment of prostate cancer vary by region Urology ·Mary Collins, Michael J. Barry, Anthony L. Zietman, Peter C. Albertsen, James A. Talcott, Elizabeth Walker Corkery, David B. Elliott, Floyd J. Fowler	2002	21
13	Sexuality after treatment for early prostate cancer Journal of General Internal Medicine ·Barbara G. Bokhour, Jack A. Clark, Thomas S. Inui, Rebecca A. Silliman, James A. Talcott	2001	195
14	Assessing suspected spinal cord compression Supportive Care in Cancer ·James A. Talcott, Paul C. Stomper, Frank W. Drislane, Patrick Y. Wen, Caroline Block, Charles C. Humphrey, Charles Lu, Ferenc Jolesz	1999	13
15	Patient-Reported Impotence and Incontinence After Nerve-Sparing Radical Prostatectomy JNCI Journal of the National Cancer Institute ·James A. Talcott, Patricia P. Rieker, K J Propert, Jack A. Clark, Philip W. Kantoff, Kenneth I. Wishnow, Kevin R. Loughlin, John P. Richie	1997	268
16	QUALITY OF LIFE IN EARLY PROSTATE CANCER Hematology/Oncology Clinics of North America ·James A. Talcott	1996	14
17	Home antibiotic therapy for low-risk cancer patients with fever and neutropenia: a pilot study of 30 patients based on a validated prediction rule. Journal of Clinical Oncology ·James A. Talcott, Anne M. Whalen, Jack A. Clark, Patricia P. Rieker, Robert W. Finberg	1994	182
18	Zygomycosis Due to Mucor circinelloides in a Neutropenic Patient Receiving Chemotherapy for Acute Myelogenous Leukemia Clinical Infectious Diseases ·Joyce D. Fingeroth, Randy S. Roth, James A. Talcott, M G Rinaldi	1994	37
19	Risk assessment in cancer patients with fever and neutropenia: a prospective, two-center validation of a prediction rule. Journal of Clinical Oncology ·James A. Talcott, Robert D. Siegel, Robert W. Finberg, L Goldman	1992	398
20	Ins(10;19) in an endometrial stromal sarcoma Cancer Genetics and Cytogenetics ·Paola Dal Cin, James A. Talcott, Jacki Abrams, Frederick P. Li, Avery A. Sandberg	1988	25

About James A. Talcott

James A. Talcott is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Urology, Clinical Biochemistry and Emergency Medicine, having authored 94 papers that have together received 6.7k indexed citations. Recurring topics across this work include Prostate Cancer Diagnosis and Treatment (42 papers), Prostate Cancer Treatment and Research (30 papers), Neutropenia and Cancer Infections (16 papers), Hematological disorders and diagnostics (9 papers), Cancer survivorship and care (9 papers), Global Cancer Incidence and Screening (9 papers), Urinary Bladder and Prostate Research (8 papers) and Health Systems, Economic Evaluations, Quality of Life (8 papers). The work is most often cited by research in Clinical Biochemistry (1.0k citations), Oncology (3.1k citations), Pulmonary and Respiratory Medicine (3.1k citations), Urology (554 citations) and Emergency Medicine (700 citations). James A. Talcott has collaborated with scholars based in United States, Canada and Netherlands. Frequent co-authors include Jack A. Clark, Philip W. Kantoff, Patricia P. Rieker, Robert W. Finberg, Robert D. Siegel, L Goldman, Ronald C. Chen, Rebecca A. Silliman, Thomas S. Inui and Kenneth V. I. Rolston. Their work appears in journals such as Journal of Clinical Oncology, Cancer, International Journal of Radiation Oncology*Biology*Physics, The Journal of Urology and Urologic Oncology Seminars and Original Investigations.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact